Genovate Biotechnology Co., Ltd. (TPEX:4130)

Genovate Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	491.23	510.86	528.51	438.76	434.25	472.72
Revenue Growth (YoY)	-4.07%	-3.34%	20.46%	1.04%	-8.14%	1.50%
Cost of Revenue	315.72	318.21	317.6	283.89	284.5	279.62
Gross Profit	175.51	192.65	210.92	154.87	149.75	193.11
Selling, General & Admin	110.38	109.74	110.31	106.89	95.49	98.71
Research & Development	60.48	59.49	73.61	61.88	55.43	54.93
Operating Expenses	170.86	169.22	183.91	168.76	150.92	153.61
Operating Income	4.65	23.43	27.01	-13.89	-1.17	39.5
Interest Expense	-0.74	-0.52	-0.27	-0.28	-0.25	-0.25
Interest & Investment Income	6.45	6.5	5.02	2.67	1.61	2.17
Earnings From Equity Investments	-1.75	-0.96	-3.88	0.29	0.14	-1.63
Currency Exchange Gain (Loss)	0.43	0.43	0.21	0.44	-0.19	-0.17
Other Non Operating Income (Expenses)	2.49	1.71	2.29	1.65	3.44	1.23
EBT Excluding Unusual Items	11.54	30.59	30.39	-9.12	3.57	40.85
Gain (Loss) on Sale of Investments	0.49	0.47	0.45	0.07	-	0
Gain (Loss) on Sale of Assets	-	-	-	-	-	-0.09
Other Unusual Items	-	-	-0.01	0.05	-	-
Pretax Income	12.03	31.06	30.83	-9	3.57	40.76
Income Tax Expense	1.1	5.36	1.49	3.32	3.2	2.03
Net Income	10.93	25.7	29.33	-12.32	0.37	38.73
Net Income to Common	10.93	25.7	29.33	-12.32	0.37	38.73
Net Income Growth	-31.14%	-12.39%	-	-	-99.04%	13.73%
Shares Outstanding (Basic)	114	115	115	113	113	113
Shares Outstanding (Diluted)	114	115	115	113	113	114
Shares Change (YoY)	-0.95%	-0.22%	1.49%	-0.03%	-0.14%	-1.44%
EPS (Basic)	0.10	0.22	0.26	-0.11	0.00	0.34
EPS (Diluted)	0.10	0.22	0.25	-0.11	0.00	0.34
EPS Growth	-27.43%	-12.01%	-	-	-99.15%	15.34%
Free Cash Flow	-27.57	24.34	56.81	-22.04	-35.22	60.07
Free Cash Flow Per Share	-0.24	0.21	0.49	-0.19	-0.31	0.53
Dividend Per Share	0.098	0.098	0.143	0.167	0.333	0.383
Dividend Growth	-31.37%	-31.37%	-14.29%	-49.98%	-12.94%	-10.06%
Gross Margin	35.73%	37.71%	39.91%	35.30%	34.48%	40.85%
Operating Margin	0.95%	4.59%	5.11%	-3.17%	-0.27%	8.36%
Profit Margin	2.22%	5.03%	5.55%	-2.81%	0.09%	8.19%
Free Cash Flow Margin	-5.61%	4.76%	10.75%	-5.02%	-8.11%	12.71%
EBITDA	40.22	58.01	60.9	19.94	32.33	72.32
EBITDA Margin	8.19%	11.36%	11.52%	4.54%	7.45%	15.30%
D&A For EBITDA	35.57	34.58	33.9	33.83	33.5	32.83
EBIT	4.65	23.43	27.01	-13.89	-1.17	39.5
EBIT Margin	0.95%	4.59%	5.11%	-3.17%	-0.27%	8.36%
Effective Tax Rate	9.14%	17.26%	4.84%	-	89.57%	4.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.